JamesStevenEconomouMDPhD
General Surgery • Los Angeles, CASurgical Oncology (Other than Breast)
Professor, Surgery, UCLA School of Medicine
Are you Dr. Economou?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 118 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 Medical Plaza
120
Los Angeles, CA 90095Phone+1 310-794-1646Fax+1 310-825-2644- Is this information wrong?
Summary
- Dr. James Economou, MD is a general surgeon in Los Angeles, California. He is currently licensed to practice medicine in California and Maryland. He is affiliated with Ronald Reagan UCLA Medical Center and UCLA Medical Center-Santa Monica.
Education & Training
University of California (San Francisco)Residency, Surgery, 1983 - 1986
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Urology, 1982 - 1983- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Surgery, 1980 - 1982
Johns Hopkins University School of MedicineClass of 1980
Certifications & Licensure
CA State Medical License 1982 - 2025
MD State Medical License 1980 - 1990- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Vaccine Therapy in Treating Patients With Liver Cancer Start of enrollment: 1999 Jul 01
- Vaccine Therapy in Treating Patients With Liver Cancer Start of enrollment: 2001 Jan 01
- Vaccine Therapy in Treating Patients With Stage IV or Recurrent Malignant Melanoma Start of enrollment: 2002 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- One of the Most Important Phone Calls of My CareerJames S. Economou> ;Annals of Surgery. 2021 Jun 1
- 9 citationsInterleukin 32 expression in human melanoma.Helicia Paz, Jennifer Tsoi, Anusha Kalbasi, Catherine S. Grasso, William H. McBride, Dörthe Schaue, Lisa H. Butterfield, Deena M. Maurer, Antoni Ribas, Thomas G. Graeb...> ;Journal of Translational Medicine. 2019 Apr 5
- 3 citationsCharacterization of Postinfusion Phenotypic Differences in Fresh Versus Cryopreserved TCR Engineered Adoptive Cell Therapy Products.Theodore S. Nowicki, Helena Escuin-Ordinas, Earl Avramis, Bartosz Chmielowski, Thinle Chodon, Beata Berent-Maoz, Xiaoyan Wang, Paula Kaplan-Lefko, Lili Yang, David Bal...> ;Journal of Immunotherapy. 2018 Jun 1
- Join now to see all
Press Mentions
UC Davis Health Surgery Chair to Lead Prestigious OrganizationApril 22nd, 2021- IconOVir Bio Announces Formation of Scientific Advisory BoardApril 20th, 2021
- Resiliency of a Perpetual Optimist: Neurosurgeon Dr. Linda LiauMarch 2nd, 2021
- Join now to see all
Grant Support
- PET Imaging Of MART Tcr-Engineered CD8 T Cell Immunotherapy In ManNational Cancer Institute2007–2011
- UCLA Clinical Scientist Training In Cancer Gene MedicineNational Cancer Institute2003–2007
- Dendritic Cell-Based Genetic Immunotherapy For MelanomaNational Cancer Institute2003–2007
- A Phase I Trial Testing Immunization With Dendritic Cells Pulsed With Four AFNational Center For Research Resources2005–2006
- UCLA Cancer Gene Medicine Training ProgramNational Cancer Institute2002–2006
- A Phase I Trial Testing MART-1 Genetic Immunization In Malignant MelanomaNational Center For Research Resources2005
- Phase I Trial Testing MART-1 Genetic Immunization In MNational Center For Research Resources2004
- Phase I Trial Testing Immunization With Dendritic CellNational Center For Research Resources2004
- Genetic Immunotherapy For Hepatocellular CancerNational Cancer Institute2001–2004
- Dendritic Cell Based Genetic Immunotherapy For MelanomaNational Cancer Institute1999–2002
- Clinical Scientist Training In Cancer Gene MedicineNational Cancer Institute1997–2002
- UCLA Gene Medicine Training ProgramNational Cancer Institute1997–2001
- Genetic Immunization Of Hepatocellular CancerNational Cancer Institute1998–2000
- Gene Therapy Of MelanomaNational Cancer Institute1995–1998
- Core--Vector Core LaboratoryNational Cancer Institute1995–1998
- Gene Therapy For CancerNational Cancer Institute1992–1998
- Phase I Trial Testing Genetically-Engineered Interleukin-7 MelanomaNational Center For Research Resources1996–1997
- Treatment Of Patients With Metastatic Melanoma And Renal Cell CancerNational Center For Research Resources1995
- Therapeutic Regulation Of TNF In IL-2 ImmunotherapyNational Cancer Institute1989–1993
- Regulation Of Macrophage Function By Interleukin-2National Cancer Institute1988–1990
Professional Memberships
- Member
- Member
Hospital Affiliations
Ronald Reagan UCLA Medical CenterLos Angeles, California- UCLA Medical Center-Santa MonicaSanta Monica, California
